Funian Lu

1.3k total citations
19 papers, 359 citations indexed

About

Funian Lu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Funian Lu has authored 19 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Funian Lu's work include PARP inhibition in cancer therapy (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and CAR-T cell therapy research (2 papers). Funian Lu is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and CAR-T cell therapy research (2 papers). Funian Lu collaborates with scholars based in China, United States and Canada. Funian Lu's co-authors include Gang Chen, Rourou Xiao, Bin Yang, Chen Zhao, Honglei Chen, Ensong Guo, Xianda Zhao, Lixin You, Zhenkun Wang and Chaoyang Sun and has published in prestigious journals such as Nature Communications, Cancer Research and British Journal of Cancer.

In The Last Decade

Funian Lu

18 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Funian Lu China 13 197 117 76 52 41 19 359
Dingqing Feng China 14 269 1.4× 104 0.9× 101 1.3× 94 1.8× 54 1.3× 37 484
Aušra Sasnauskienė Lithuania 10 198 1.0× 87 0.7× 91 1.2× 49 0.9× 37 0.9× 23 366
Qisang Guo China 12 156 0.8× 61 0.5× 97 1.3× 65 1.3× 56 1.4× 20 315
Stephanie Gomez United States 7 336 1.7× 129 1.1× 127 1.7× 128 2.5× 33 0.8× 10 517
Xiangpeng Dai China 14 427 2.2× 102 0.9× 135 1.8× 57 1.1× 28 0.7× 44 629
April Alexander United States 5 178 0.9× 211 1.8× 59 0.8× 62 1.2× 49 1.2× 5 376
Xiuqin Li China 9 243 1.2× 154 1.3× 65 0.9× 27 0.5× 36 0.9× 14 432
Yarely M. Salinas-Vera Mexico 13 315 1.6× 104 0.9× 267 3.5× 29 0.6× 24 0.6× 24 451
Cailing Ma China 12 257 1.3× 57 0.5× 211 2.8× 71 1.4× 140 3.4× 30 597

Countries citing papers authored by Funian Lu

Since Specialization
Citations

This map shows the geographic impact of Funian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funian Lu more than expected).

Fields of papers citing papers by Funian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Funian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funian Lu. The network helps show where Funian Lu may publish in the future.

Co-authorship network of co-authors of Funian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Funian Lu. A scholar is included among the top collaborators of Funian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Funian Lu. Funian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fu, Yu, Xiaoyan Kang, Wenting Li, et al.. (2025). The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy. Cell Reports. 44(5). 115605–115605.
2.
Yang, Xiaohang, Jingjing Yin, Wenting Li, et al.. (2024). Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation. Nature Communications. 15(1). 2089–2089. 8 indexed citations
3.
Xiao, Rourou, Yu Fu, Bin Yang, et al.. (2023). MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC. Cell & Bioscience. 13(1). 178–178. 3 indexed citations
4.
Wang, Wei, Si Liu, Funian Lu, et al.. (2023). STAT4, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion. Oncology Reports. 50(1). 4 indexed citations
5.
Wang, Wei, Yuxuan Xiong, Funian Lu, et al.. (2022). Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity. Acta Biomaterialia. 157. 428–441. 17 indexed citations
6.
Qin, Tianyu, Junpeng Fan, Funian Lu, et al.. (2022). Harnessing preclinical models for the interrogation of ovarian cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 277–277. 15 indexed citations
7.
Yang, Bin, Xi Li, Yu Fu, et al.. (2021). MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors. Cancer Research. 81(10). 2714–2729. 38 indexed citations
8.
Wang, Zhenkun, Ensong Guo, Bin Yang, et al.. (2021). Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer. Gynecologic Oncology. 163(2). 358–363. 68 indexed citations
9.
Huang, Jia, Wanying Shan, Fuxia Li, et al.. (2021). Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice. Aging. 13(5). 7589–7607. 17 indexed citations
10.
11.
Wang, Zizhuo, Rourou Xiao, Jia Huang, et al.. (2021). The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer. Microbial Ecology. 84(1). 302–313. 20 indexed citations
12.
Qin, Tianyu, Ensong Guo, Funian Lu, et al.. (2021). Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors. Aging. 13(23). 24943–24962. 3 indexed citations
13.
Li, Fuxia, Ensong Guo, Jia Huang, et al.. (2020). mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers.. American Journal of Cancer Research. 10(3). 908–924. 14 indexed citations
14.
15.
Zhao, Chen, Aili Wang, Funian Lu, et al.. (2017). Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients. Tumor Biology. 39(2). 2901568632–2901568632. 23 indexed citations
16.
Zhao, Chen, Funian Lu, Hongxia Chen, et al.. (2016). Clinical significance of circulating miRNA detection in lung cancer. Medical Oncology. 33(5). 41–41. 26 indexed citations
17.
Zhao, Chen, et al.. (2014). Dysregulation of JAM-A plays an important role in human tumor progression.. PubMed. 7(10). 7242–8. 33 indexed citations
18.
Lu, Funian, et al.. (2006). Nuclear ING2 expression is reduced in human cutaneous melanomas. British Journal of Cancer. 95(1). 80–86. 33 indexed citations
19.
King, Leslie B., Eva Tolosa, Funian Lu, et al.. (1999). A dominant-negative mutant of c-Jun inhibits cell cycle progression during the transition of CD4–CD8– to CD4+CD8+ thymocytes. International Immunology. 11(8). 1203–1216. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dingqing Feng Breakdown of academic impact, for papers by Aušra Sasnauskienė Breakdown of academic impact, for papers by Qisang Guo Breakdown of academic impact, for papers by Stephanie Gomez Breakdown of academic impact, for papers by Xiangpeng Dai Breakdown of academic impact, for papers by April Alexander Breakdown of academic impact, for papers by Xiuqin Li Breakdown of academic impact, for papers by Yarely M. Salinas-Vera Breakdown of academic impact, for papers by Cailing Ma
Rankless by CCL
2026